document_id
stringlengths 32
32
| age
int64 17
105
| gender
stringclasses 2
values | test_name
stringlengths 1
100
⌀ | display_ranges
stringlengths 1
662
⌀ | value
stringlengths 1
255
| unit
stringlengths 1
15
⌀ | specimen
stringclasses 12
values | loinc
stringclasses 581
values |
---|---|---|---|---|---|---|---|---|
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | POST PRANDIAL BLOOD SUGAR ( PP ) Hexokinase | non-diabetic 74-140
diabetic
200
pre-diabetic 141-199 | 133.3000 | mg/dl | blood | 1521-4 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | Platelet count | 150.0 - 410.0 | 240.0000 | X 10^3 / ul | blood | 26515-7 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | RBCs | 4.5 - 5.5 | 4.8300 | 10^6/uL | blood | 26453-1 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | RED CELL DISTRIBUTION WIDTH-CV (RDW-CV) | 11.6 - 14.0 | 13.2000 | % | blood | 30385-9 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | RED CELL DISTRIBUTION WIDTH-SD (RDW-SD) | 35.0 - 56.0 | 42.7000 | fL | blood | 30384-2 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | Total Cholesterol / HDL Cholesterol Ratio | 0.0 - 5.0 | 6.1600 | RATIO | blood | 9830-1 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | Total Leucocyte Count | 4.0 - 11.0 | 8.6000 | X 10^3 / uL | blood | 26464-8 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | Triglyceride Enzymatic Endpoint | normal: < 180
borderline high: 180-229
high: 230-499
very high: >= 500 | 212.3000 | mg / dl | blood | 2571-8 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | ULTRASENSITIVE THYROID STIMULATING HORMONE (TSH) | 0.27 - 4.2 | 0.4200 | ulU/mL | blood | 3016-3 |
61da6e85a186a13bcad87f6d3b67e8cd | 59 | male | VLDL Cholesterol Calculated | 0.0 - 40.0 | 27.2000 | mg / di | blood | 2091-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Absolute Basophil Count | 20.0 - 100.0 | 0E-30 | /c.mm | blood | 26444-0 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Absolute Eosinophil Count | 20.0 - 500.0 | 328.0000 | /c.mm | blood | 26449-9 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Absolute Lymphocyte Count | 1000.0 - 3000.0 | 2050.0000 | /c.mm | blood | 26474-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Absolute Monocyte Count | 200.0 - 1000.0 | 656.0000 | /c.mm | blood | 26484-6 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Absolute Neutrophils Count | 2000.0 - 7000.0 | 5166.0000 | /c.mm | blood | 26499-4 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Basophils | 0.0 - 2.0 | 0E-30 | % | blood | 30180-4 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Eosinophils | 1.0 - 6.0 | 4.0000 | % | blood | 26450-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Erythrocyte (RBC) Count | 4.2 - 5.4 | 4.5700 | mill/cu.mm | blood | 26453-1 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Haemoglobin (Hb) | 12.0 - 16.0 | 12.4000 | gm/dL | blood | 718-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Lymphocytes | 20.0 - 40.0 | 25.0000 | % | blood | 26478-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | MCH (Mean Corpuscular Hb) | 27.0 - 31.0 | 27.2000 | pg | blood | 28539-5 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | MCHC (Mean Corpuscular Hb Concn.) | 32.0 - 36.0 | 32.3000 | g/dL | blood | 28540-3 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | MCV (Mean Corpuscular Volume) | 82.0 - 101.0 | 84.2000 | fL | blood | 30428-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | MPV (Mean Platelet Volume) | 6-9.5
not detected | 6.4000 | fL | blood | 28542-9 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Monocytes | 2.0 - 10.0 | 8.0000 | % | blood | 26485-3 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Neutrophils | 40.0 - 80.0 | 63.0000 | % | blood | 53797-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | PCV (Packed Cell Volume) | 37.0 - 47.0 | 38.5000 | % | blood | 20570-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Platelet count | 140.0 - 440.0 | 428.0000 | X 10^3/ul | blood | 26515-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | RDW (Red Cell Distribution Width) | 11.5 - 14.0 | 13.4000 | % | blood | 30385-9 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Total Leucocytes (WBC) count | 4300.0 - 10300.0 | 8200.0000 | cells/cu.mm | blood | 26464-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | CHOL/HDL RATIO | 3.5 - 5.0 | 5.1200 | ratio | blood | 9830-1 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Cholesterol-Total | desirable: < 200
borderline high: 200-239
high: >= 240 | 209.0000 | mg/dL | blood | 2093-3 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | HDL Cholesterol | major risk factor for heart
disease: < 40
negative risk factor for heart
disease: >= 60 | 40.8000 | mg/dL | blood | 2085-9 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | LDL Cholesterol (Calculated) | optimal: < 100
near optimal: 100-129
borderline high: 130-159
high: 160-189
very high: >= 190 | 128.8000 | mg/dL | blood | 2089-1 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | LDL/HDL RATIO | 2.5 - 3.5 | 3.1600 | ratio | blood | 11054-4 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Non HDL Cholesterol | optimal: < 130
desirable: 130-159
borderline high: 159-189
high: 189-220
very high: >= 220 | 168.2000 | mg/dL | blood | 43396-1 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Triglycerides level | normal: < 150
borderline high: 150-199
high: 200-499
very high: >= 500
reference: recomended ncep
guidelines | 197.0000 | mg/dL | blood | 2571-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | VLDL Cholesterol (Calculated) | 6.0 - 38.0 | 39.4000 | mg/dL | blood | 2091-7 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Albumin-Microalb/Creatinine Ratio | normal: < 30
microalbuminuria: 30-299
clinical albuminuria: > 300 | 20.5200 | ug/mg | urine | null |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Albumin/Microalbumin in Urine | null | 14.0000 | mg/L | urine | 14957-5 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Creatinine, Urine by Jaffe Method | null | 68.2300 | mg/dL | urine | 2161-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | SGOT (AST) | < 35.0 | 22.0000 | U/L | null | 1920-8 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | SGPT (ALT) | < 35.0 | 28.0000 | U/L | blood | 1742-6 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Uric Acid | 2.4 - 5.7 | 2.7000 | mg/dL | blood | 3084-1 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | TSH by ECLIA | 0.45-4.5
first trimester 0.1-2.5
second trimester 0.2-3.0
third trimester 0.3-3.0 | 5.1700 | ulU/mL | null | 3016-3 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | Creatinine | 0.5 - 0.9 | 0.5200 | mg/dL | null | 2160-0 |
8a35f22799da3e136e6bf908b880d627 | 43 | female | eGFR by Creatinine | normal or high: >= 90
mild decrease 60-89
mild moderate decrease: 45-59
moderate to severe decrease:
30-44
severe decrese: 15-29
kidney failure: < 15 | above 90 | ml/min/1.73 | null | 69405-9 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Estimated average glucose (eAG) | null | 119.7600 | mg/dL | blood | 27353-2 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Glycosylated Hemoglobin (HbA1c) | 4.0 - 5.6 | 5.8000 | % | blood | 4548-4 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Absolute Basophil Count | 0.02 - 0.1 | 0.0100 | 10^3/uL | blood | 26444-0 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Absolute Eosinophil Count | 0.02 - 0.5 | 0.4200 | 10^3/uL | blood | 26449-9 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Absolute Lymphocyte Count | 1.0 - 3.0 | 2.0100 | 10^3/uL | blood | 26474-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Absolute Monocyte Count | 0.2 - 1.0 | 0.2900 | 10^3/uL | blood | 26484-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Absolute Neutrophil Count | 2.0 - 7.0 | 2.3200 | 10^3/uL | blood | 26499-4 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Basophils | 0.0 - 2.0 | 0.1000 | % | blood | 30180-4 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Eosinophils | 1.0 - 6.0 | 8.4000 | % | blood | 26450-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | HCT | 40.0 - 50.0 | 37.8000 | % | blood | 20570-8 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Hemoglobin | 13.0 - 17.0 | 12.4000 | g/dL | blood | 718-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Lymphocytes | 20.0 - 40.0 | 39.8000 | % | blood | 26478-8 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | MCH | 27.0 - 32.0 | 28.5000 | pg | blood | 28539-5 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | MCHC | 31.5 - 34.5 | 32.7000 | g/dL | blood | 28540-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | MCV | 83.0 - 101.0 | 87.1000 | fL | blood | 30428-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | MPV | 6.5 - 12.0 | 10.3000 | fL | blood | 28542-9 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Monocytes | 2.0 - 10.0 | 5.8000 | % | blood | 26485-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Neutrophils | 40.0 - 80.0 | 45.9000 | % | blood | 53797-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | PDW | 9.0 - 17.0 | 18.0000 | fL | blood | 32207-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Platelet Count | 150.0 - 410.0 | 191.0000 | 10^3/uL | blood | 26515-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | RBC | 4.5 - 5.5 | 4.3400 | 10^6/cu.mm | blood | 26453-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | RDW-CV | 11.6 - 14.0 | 16.0000 | % | blood | 30385-9 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Total Leucocyte Count | 4.0 - 10.0 | 5.0500 | 10^3/uL | blood | 26464-8 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Cholesterol Total | desirable <200,
borderline high 200-239,
high >=240 | 188.0000 | mg/dL | blood | 2093-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Glucose Fasting | 70-99
hexokinase | 97.0000 | mg/dL | blood | 1558-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Cholesterol : HDL Cholesterol | desirable : 3.5-4.5
high risk : >5 | 5.5000 | Ratio | blood | 9830-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Cholesterol HDL | undesirable/high risk
<=40
desirable/low
risk>=60 | 33.0000 | mg/dL | blood | 2085-9 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Cholesterol LDL | desirable: <100
above desirable: 100
129
borderline high : 130
159
high : 160-189
very high : >=190 | 118.0000 | mg/dL | blood | 2089-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Cholesterol- VLDL | < 30.0 | 31.0000 | mg/dl | blood | 2091-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | LDL : HDL Cholesterol | desirable : 2.5-3.0
high risk : >3.5 | 3.5800 | Ratio | blood | 11054-4 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Non HDL Cholesterol | desirable: < 130,
above desirable: 130
159,
borderline high: 160
189,
high: 190-219,
very high: >= 220 | 149.0000 | mg/dl | blood | 43396-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Triglycerides | normal: <150,
borderline: 150-199,
igh:200-499,
very high>=500 | 156.0000 | mg/dL | blood | 2571-8 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | A/G Ratio | 0.8 - 2.1 | 1.9800 | Ratio | blood | 1759-0 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Alanine Transaminase (SGPT) | 10.0 - 49.0 | 178.0000 | U/L | blood | 1742-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Albumin | 3.4 - 4.8 | 4.4500 | g/dL | blood | 1751-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Alkaline Phosphatase | 46.0 - 116.0 | 80.0000 | U/L | blood | 6768-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Aspartate Transaminase (SGOT) | < 34.0 | 88.0000 | U/L | blood | 1920-8 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Bilirubin-Direct | 0.0 - 0.3 | 0.1200 | mg/dl | blood | 1968-7 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Bilirubin-Indirect | 0.2 - 0.8 | 0.2300 | mg/dL | blood | 1971-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Bilirubin-Total | 0.3 - 1.2 | 0.3500 | mg/dl | blood | 1975-2 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Gamma Glutamyltransferase (GGT) | < 73.0 | 35.0000 | U/L | blood | 2324-2 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Globulin | 2.1 - 3.9 | 2.2000 | g/dl | blood | 2336-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Protein, Total | 5.7 - 8.2 | 6.7000 | g/dL | blood | 2885-2 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | SGOT/SGPT | < 1.0 | 0.4900 | Ratio | blood | 1916-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | BUN/Creatinine Ratio | 12:1-20:1 | 16.7000 | Ratio | blood | 3097-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Blood Urea Nitrogen | 9.0 - 23.0 | 13.0000 | mg/dL | blood | 3094-0 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Chloride | 99.0 - 109.0 | 105.0000 | mmol/L | blood | 2075-0 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Creatinine | 0.7 - 1.3 | 0.7800 | mg/dL | blood | 2160-0 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Potassium | 3.5 - 5.5 | 4.4000 | mmol/L | blood | 2823-3 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Sodium | 132.0 - 146.0 | 139.0000 | mmol/L | blood | 2951-2 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Urea | 19.26 - 49.22 | 27.8200 | mg/dl | blood | 3091-6 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Uric Acid | 3.5 - 7.2 | 7.3000 | mg/dL | blood | 3084-1 |
2f559a8f449f646825c469bb2c0b4f40 | 33 | male | Insulin- Postprandial | null | 68.6100 | uU/mL | blood | null |
Subsets and Splits